Silicone sealant
Bharat Heavy Electricals Limited (bhel)
BANGALORE, KARNATAKA
Bid Publish Date
17-Feb-2026, 10:29 am
Bid End Date
23-Feb-2026, 11:00 am
Location
Progress
Quantity
3
Bid Type
Single Packet Bid
The Department Of Health Research in BHOPAL, Madhya Pradesh seeks supply of a fibrin sealant with explicit aprotinin present and a defined source of aprotinin. The procurement scope is limited to the supply of Goods (no installation) with an unspecified estimated value and no BOQ items listed. Key differentiators include compliance with specified content and packaging terms, and a focus on pharmaceutical-grade sourcing. The tender emphasis is on product integrity, traceability of aprotinin origin, and packaging specifics that support safe hospital use.
Product: Fibrin Sealant (Q2) with aprotinin present
Key test/quality: Batch-wise source of aprotinin documentation and C of A
Packaging: Defined pack size suitable for single-use clinical application
Documentation: GMP compliance, shelf-life details, sterile packaging
EMD amount not disclosed in data; verify at bid stage
Delivery schedule and payment terms to be defined in purchase order
Warranty/after-sales terms unspecified; confirm with issuing authority
Details to be provided in final tender; bidders should prepare for standard public procurement terms.
Delivery timelines to be specified in purchase order; ensure alignment with hospital usage needs.
Not available in current data; expect standard LD for late delivery or non-conformance in final documents.
Experience in supplying fibrin sealants or similar hemostatic products to healthcare facilities
Valid GMP/QA certifications and ability to provide C of A for each lot
Ability to provide clear sourcing documentation for aprotinin
Main Document
CATALOG Specification
GEM_GENERAL_TERMS_AND_CONDITIONS
Bharat Heavy Electricals Limited (bhel)
BANGALORE, KARNATAKA
Odisha Power Generation Corporation Limited
JHARSUGUDA, ODISHA
South Central Railway
KRISHNA, ANDHRA PRADESH
Southern Railway
Central Railway
Tender Results
Loading results...
| Category | Specification | Requirement |
|---|---|---|
| PRODUCT SPECIFICATION | Aprotinin present | Yes, No |
| PRODUCT SPECIFICATION | Source of aprotinin | Synthetic Aprotinin (Bovine-Free), NA |
| PACKAGING | Pack Size | 2 mL Kit (Fibrinogen 1mL and Thrombin 1mL) |
Discover companies most likely to bid on this tender
GST registration certificate
PAN card
Experience certificates for prior supply of fibrin sealants or similar hemostatic products
Financial statements for the last 2 fiscal years
EMD/Security deposit as per tender terms (amount not specified in data)
Technical bid documents including GMP/QA certificates
OEM authorization (if applicable) and source declaration for aprotinin
Certificate of analysis and shelf-life data for the fibrin sealant
Product datasheet showing presence and sourcing of aprotinin
Extended Deadline
23-Feb-2026, 11:00 am
Opening Date
23-Feb-2026, 11:30 am
Key insights about MADHYA PRADESH tender market
Bidders must submit GST, PAN, experience certificates, financial statements, EMD, and technical bids with GMP/QA attestations. Provide explicit documentation on aprotinin presence and source. Ensure pack size data and shelf-life details are included, and follow department filing rules for pharmaceuticals.
Submit GST, PAN, company registration, past supply certificates for hemostatic products, C of A for each lot, GMP/QA certifications, OEM authorizations if applicable, and the sourcing declaration for aprotinin. Include packaging specs and batch-wise traceability data.
The tender requires presence of aprotinin and a documented source. While ISI is not specified, bidders should provide C of A, GMP compliance, and batch traceability. Prepare shelf-life and storage-condition data to demonstrate product stability for hospital use.
Exact delivery timeline and payment terms will be issued in the purchase order. Prepare to meet a standard public procurement cadence with delivery aligned to hospital demand and payment after delivery per vendor terms; confirm currency and tax components in final docs.
Demonstrate prior experience supplying fibrin sealants or similar hemostatic agents to healthcare facilities, provide GMP/QA certificates, and show sourcing traceability for aprotinin. Include financials proving capacity to fulfill public contract obligations.
Tender requires explicit documentation on the source of aprotinin and confirmation of its presence in the fibrin sealant. Suppliers should attach sourcing declarations and supplier certificates confirming raw material origin to ensure traceability.
Provide exact pack sizes suitable for single-use administration, ensure sterile packaging, and include shelf-life data. Packaging must preserve sterility and product integrity during storage under hospital conditions.
Current data does not specify LD terms; bidders should expect standard liquidated damages for delays in public procurement. Confirm LD rate, start date, and grace periods in the final tender documentation.
Sign up now to access all documents
Main Document
CATALOG Specification
GEM_GENERAL_TERMS_AND_CONDITIONS